Brendan Mouatt, Tasha R Stanton, G Lorimer Moseley, Aidan G Cashin, Laura E Simons, Hayley B Leake, Felicity A Braithwaite
{"title":"Effect of depression screening on future depressive symptoms in a persistent pain population: mediation analysis.","authors":"Brendan Mouatt, Tasha R Stanton, G Lorimer Moseley, Aidan G Cashin, Laura E Simons, Hayley B Leake, Felicity A Braithwaite","doi":"10.1097/PR9.0000000000001453","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Clinical guidelines for persistent pain recommend screening for psychosocial factors. However, little is known about whether completing a structured depression questionnaire within a clinical encounter is associated with subsequent depressive symptom trajectories.</p><p><strong>Objective: </strong>To evaluate whether exposure to such a questionnaire is associated with depressive symptoms at 6-month follow-up, and, if so, whether the association remains after removing the effects of referral to, or engagement with, psychological care.</p><p><strong>Methods: </strong>We analysed clinical audit data from patients with persistent pain who were quasi-randomly allocated to complete full depression screening using the Patient Health Questionnaire-9 (PHQ-9) or a pain-knowledge questionnaire. The primary outcome was depressive symptoms at 6-month follow-up, using a validated single-item 0 to 10 mood rating scale. Causal mediation analysis estimated the direct effect of depression screening on follow-up mood by blocking effects of referral to, and engagement with, psychological care.</p><p><strong>Results: </strong>A total of 1779 participants (age [mean ± SD] = 42.7 ± 11.1 years; pain duration [mean ± SD] = 54.3 ± 29.9 months) were included. At 6-month follow-up, mood numerical rating scale scores improved in both groups (PHQ-9 group [n = 886] = -1.3 points [SD = 1.3]; pain-knowledge questionnaire group [n = 893] = -2.0 points [SD = 1.8]); the PHQ-9 group reported less improvement (mean difference = 0.7/10 points, 95% CI = 0.5-0.8). When referral for (n = 646) and engaging with psychological care (n = 466) were blocked, the direct effect remained (0.5/10 points, 95% CI = 0.3-0.6, 0.4/10 points, 95% CI = 0.2-0.6; respectively).</p><p><strong>Conclusion: </strong>Exposure to screening had smaller reduction in depressive symptoms 6 months later than those who completed a pain-knowledge questionnaire, regardless of referral for, or engagement with, psychological care. Future research should examine how assessment processes influence patient sense-making, clinician responses, and referral pathways in pain care.</p>","PeriodicalId":52189,"journal":{"name":"Pain Reports","volume":"11 4","pages":"e1453"},"PeriodicalIF":4.3000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13229457/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/PR9.0000000000001453","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Clinical guidelines for persistent pain recommend screening for psychosocial factors. However, little is known about whether completing a structured depression questionnaire within a clinical encounter is associated with subsequent depressive symptom trajectories.
Objective: To evaluate whether exposure to such a questionnaire is associated with depressive symptoms at 6-month follow-up, and, if so, whether the association remains after removing the effects of referral to, or engagement with, psychological care.
Methods: We analysed clinical audit data from patients with persistent pain who were quasi-randomly allocated to complete full depression screening using the Patient Health Questionnaire-9 (PHQ-9) or a pain-knowledge questionnaire. The primary outcome was depressive symptoms at 6-month follow-up, using a validated single-item 0 to 10 mood rating scale. Causal mediation analysis estimated the direct effect of depression screening on follow-up mood by blocking effects of referral to, and engagement with, psychological care.
Results: A total of 1779 participants (age [mean ± SD] = 42.7 ± 11.1 years; pain duration [mean ± SD] = 54.3 ± 29.9 months) were included. At 6-month follow-up, mood numerical rating scale scores improved in both groups (PHQ-9 group [n = 886] = -1.3 points [SD = 1.3]; pain-knowledge questionnaire group [n = 893] = -2.0 points [SD = 1.8]); the PHQ-9 group reported less improvement (mean difference = 0.7/10 points, 95% CI = 0.5-0.8). When referral for (n = 646) and engaging with psychological care (n = 466) were blocked, the direct effect remained (0.5/10 points, 95% CI = 0.3-0.6, 0.4/10 points, 95% CI = 0.2-0.6; respectively).
Conclusion: Exposure to screening had smaller reduction in depressive symptoms 6 months later than those who completed a pain-knowledge questionnaire, regardless of referral for, or engagement with, psychological care. Future research should examine how assessment processes influence patient sense-making, clinician responses, and referral pathways in pain care.